Cullgen Merger Could Make Pulmatrix (PULM) a Biotech Dark Horse
Pulmatrix Inc. (NASDAQ:PULM) is a U.S.-based clinical-stage biopharmaceutical company that has carved a unique niche in the biotech…
Capricor (CAPR) Emerges as a Top Buyout Target After Breakthrough Duchenne Data
Capricor Therapeutics Inc. (NASDAQ:CAPR) is a late-stage biotechnology company at the forefront of developing transformative cell and exosome-based…
CorMedix (CRMD) Just Posted Its 1st Profit—Is This Biotech Rocket About to Launch?
CorMedix Inc. (NASDAQ: CRMD) is a commercial-stage biopharmaceutical company that has reached a rare inflection point for small-cap…
Scinai (SCNI) Jumps 29%—Biotech Investors Are Betting on Scinai’s Dual-Revenue Model
Scinai Immunotherapeutics Ltd. (NASDAQ:SCNI) is an emerging biopharmaceutical company that operates at the intersection of cutting-edge immunology research…
Protagenic (PTIX) Explodes 300% After Merger With Phytanix—Is This the Next Biotech Breakout?
Protagenic Therapeutics, Inc. (NASDAQ: PTIX) has long focused on the development of peptide-based therapeutics aimed at treating stress-related…
Windtree Therapeutics (WINT)’s Big Comeback: Will it be the Next Biotech Superstar?
Windtree Therapeutics Inc. (NASDAQ:WINT) is a clinical-stage biotechnology company at the forefront of innovation in cardiovascular medicine and…
Wall Street Isn’t Paying Attention to Revelation Bio (REVB)… Yet.
Revelation Biosciences Inc. (NASDAQ:REVB) is a clinical-stage biopharmaceutical company headquartered in San Diego, California, dedicated to transforming the…
Shuttle Pharma (SHPH) is Set to Explode: Here’s Why
Shuttle Pharmaceuticals Holdings Inc. (NASDAQ:SHPH) is a clinical-stage specialty pharmaceutical company pioneering a novel approach to cancer treatment…
Buy the Dip? Universe Pharma (UPC) Could Surge After a Brutal 2024
Universe Pharmaceuticals Inc. (NASDAQ:UPC) is a China-based pharmaceutical company dedicated to the research, development, manufacturing, marketing, and sales…
Vaxcyte (PCVX) Could Be the Next Biotech Giant in the Vaccine Industry
Vaxcyte Inc. (NASDAQ:PCVX) is a clinical-stage biotechnology company at the forefront of a new wave in vaccine innovation.…
Relay Therapeutics (RLAY) Just Got FDA Backing—Here’s Why RLAY Stock Could Explode
Relay Therapeutics Inc. (NASDAQ:RLAY) is a clinical-stage biotechnology company at the forefront of a new era in drug…
Werewolf Therapeutics (HOWL) Can Be the Next Biotech Moonshot
Werewolf Therapeutics, Inc. (NASDAQ:HOWL) is a cutting-edge biopharmaceutical company pioneering a transformative approach to cancer immunotherapy through its…
Verastem (VSTM)’s Cancer Drug Shows 83% Response Rate — Is this the Next 10x Biotech?
Verastem Oncology (NASDAQ:VSTM) is a dynamic, late-stage biopharmaceutical company dedicated to redefining the treatment landscape for some of…
Multikine’s 73% 5-Year Survival Rate Shocks Wall Street — Is CEL-SCI (CVM) the Next Big Winner?
CEL-SCI Corporation (NYSE:CVM) is a trailblazing clinical-stage biotechnology company that has spent decades at the forefront of immunotherapy…
Analysts Say Tango (TNGX) is Worth $10.43—Here’s Why It Might Go Even Higher
Tango Therapeutics Inc. (NASDAQ:TNGX) is a clinical-stage biotechnology company at the forefront of developing targeted cancer therapies using…
Is Prelude (PRLD) the Next Biotech Titan? Investors Are Watching this Stock Closely
Prelude Therapeutics Incorporated (NASDAQ:PRLD) is a clinical-stage biopharmaceutical company committed to transforming the treatment of cancer through the…
This $1 Stock Has a $6 Price Target—Is Pyxis (PYXS) the Best Cheap Biotech Play Right Now?
Pyxis Oncology Inc. (NASDAQ:PYXS) is a clinical-stage biotechnology company committed to redefining the landscape of cancer therapy through…
Foghorn Therapeutics (FHTX) is Quietly Building a Biotech Empire—Here’s Why Investors Are Watching
Foghorn Therapeutics Inc. (NASDAQ:FHTX) is a pioneering clinical-stage biotechnology company that is revolutionizing the treatment of cancer and…